PPPs and adjuvants containing unacceptable co-formulants will no longer be permitted from 24 March 2023 The EU has implemented Commission Regulation (EU) 2021/383 adding unacceptable co-formulants to Annex III of the EU PPP Regulation. This followed lengthy discussions, which the UK participated in when a Member State. This means that existing NI authorisations for PPPs and adjuvants which contain one or more of these co-formulants must be amended or withdrawn by 24 March 2023. Grace periods as specified in Regulation (EU) 2021/383 will apply. Independent consideration by HSE with the agreement of the English, Welsh, and Scottish Administrations, has found it appropriate to implement the same changes. As set out in retained legislation applicable in GB, there is to be a GB Statutory Register of unacceptable co-formulants, which will be established on HSEs website from 24 March 2023. It will be populated with the same list of unacceptable co-formulants as are included in Commission Regulation (EU) 2021/383. Affected adjuvants and PPPs will also be withdrawn in GB on 24 March 2023, with appropriate grace periods. HSE will inform stakeholders via our pesticides ebulletin when the register has been published. HSE has contacted authorisation/permit holders who our records show have PPPs or adjuvants that contain unacceptable co-formulants outlined in the EU update to Annex III. Wherever possible, HSE will seek to help stakeholders mitigate the impacts of the updates. If you have not already been contacted and believe that you will be impacted by the changes, please contact HSE. There have been recent amendments to the GB maximum residue levels (MRL) Statutory Register, setting new statutory levels. In order to meet the requirements of international trade and to address cross contamination, new MRLs have been set in the GB MRL Statutory Register for the following active/commodity combinations: Lambda cyhalothrin/ avocados Chlormequat/ cultivated fungi (except oyster mushrooms) Chlormequat/ oyster mushrooms The MRLs for chlormequat are set on a temporary basis to cover residues arising as a result of growing fungi on cereal straw lawfully treated with chlormequat. The continued validity of the tMRLs (temporary MRLs) must be reassessed by the submission of supplementary information to HSE by 9 February 2030. The full details of the supplementary information requirements are outlined in the decision document available at the link below. The new MRLs came into force on 10 February 2023 as indicated in the GB MRL Statutory Register. The footnotes outlined in the GB MRL Statutory Register relating to supplementary information requirements for mandipropamid have been deleted. This follows on from an assessment that fully addressed the data gaps identified in the MRL review. All MRLs have therefore been retained and there are no changes to the numerical values of the MRLs for mandipropamid. The evaluation reports, reasoned opinions and decision documents supporting the new MRLs and the deletion of the footnotes are available on the HSE website. If you have any questions relating to this ebulletin, please contact us. | 